Read More 2 minute read Movers 12 Health Care Stocks Moving In Tuesday’s After-Market Session By Benzinga Insights October 31, 5:31 PM Gainers Plus Therapeutics (NASDAQ:PSTV) shares rose 20.3% to $1.48 during Tuesday’s after-market session. Today’s trading volume for this… AMTI
Read More 2 minute read Movers 12 Health Care Stocks Moving In Tuesday’s Intraday Session By Benzinga Insights September 26, 1:31 PM Gainers Soleno Therapeutics (NASDAQ:SLNO) shares increased by 426.2% to $23.31 during Tuesday’s regular session. Soleno Therapeutics’s stock is… APLT
Read More 1 minute read Movers 12 Health Care Stocks Moving In Tuesday’s Pre-Market Session By Benzinga Insights September 26, 9:06 AM Gainers Soleno Therapeutics (NASDAQ:SLNO) shares increased by 386.4% to $21.55 during Tuesday’s pre-market session. The company’s market cap… BPTS
Read More 3 minute read Movers 12 Health Care Stocks Moving In Monday’s Intraday Session By Benzinga Insights September 25, 1:31 PM Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares rose 219.3% to $2.12 during Monday’s regular session. TransCode Therapeutics’s stock is trading… AVTX
Read More 11 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For September 25, 2023 By Benzinga Insights September 25, 11:00 AM Upgrades For Steel Dynamics Inc (NASDAQ:STLD), Citigroup upgraded the previous rating of Neutral to Buy. For the second… ALEC
Read More 12 minute read Options Stocks That Hit 52-Week Lows On Monday By Benzinga Insights September 11, 1:38 PM Monday's session saw 175 companies set new 52-week lows. A
Read More 17 minute read Options Stocks That Hit 52-Week Lows On Thursday By Benzinga Insights September 7, 1:55 PM On Thursday, 283 companies set new 52-week lows. AAMC
Read More 2 minute read Movers 12 Health Care Stocks Moving In Tuesday’s After-Market Session By Benzinga Insights July 4, 5:37 PM Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 11.8% to $0.52 during Tuesday’s after-market session. The company’s market… AMRX
Read More 5 minute read Biotech General News Vaccitech To Present Final Data At EASL Congress For Phase 1b/2 HBV002 Study In Adults With Chronic Hepatitis B By Happy Mohamed June 21, 9:05 AM Meaningful, durable reductions of HBsAg were seen, both in participants who received VTP-300 alone and in combination with a low-dose PD-1 inhibitor Two patients developed a non-detectable HBsAg level, which continued VACC
Read More 1 minute read Analyst Ratings Analyst Expectations for Vaccitech’s Future By Benzinga Insights June 13, 11:02 AM Within the last quarter, Vaccitech (NASDAQ:VACC) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish… VACC